Atai Life Sciences (ATAI) News Today $1.47 -0.10 (-6.37%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.49 +0.02 (+1.36%) As of 03/28/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period atai Life Sciences CEO discusses major data readouts expected through 2025 - ICYMIMarch 29 at 1:49 PM | proactiveinvestors.comInsiders Make Huge Purchases of These 4 Biotech StocksMarch 26, 2025 | 247wallst.com Biopharma exec says Bitcoin could help industry through ‘biotech winter’ March 21, 2025 | cointelegraph.comPsychedelic: atai Life Sciences, NRx report quarterly resultsMarch 21, 2025 | markets.businessinsider.com Biopharma exec says Bitcoin could help industry through ‘biotech winter’ March 21, 2025 | cointelegraph.com Biopharma exec says Bitcoin could help industry through ‘biotech winter’ March 21, 2025 | cointelegraph.com Biopharma exec says Bitcoin could help industry through ‘biotech winter’ March 20, 2025 | cointelegraph.comAtai Life Sciences Full Year 2024 Earnings: Misses ExpectationsMarch 20, 2025 | finance.yahoo.comatai Life Sciences entering catalyst-rich period with high-potential data readouts in 2025 and 2026March 18, 2025 | proactiveinvestors.comTD Cowen Keeps Their Buy Rating on ATAI Life Sciences (ATAI)March 17, 2025 | markets.businessinsider.comatai Life Sciences prepares for data readouts from key clinical trials, extends operational runwayMarch 17, 2025 | proactiveinvestors.comAtai Life Sciences reports Q4 EPS (24c), consensus (15c)March 17, 2025 | markets.businessinsider.comatai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate HighlightsMarch 17, 2025 | markets.businessinsider.comAtai Life Sciences announces first patient dosed in Elumina Phase 2 trialMarch 11, 2025 | markets.businessinsider.comatai Life Sciences doses first patient in Phase 2 treatment-resistant depression trialMarch 11, 2025 | proactiveinvestors.comatai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant DepressionMarch 11, 2025 | globenewswire.comAtai Life Sciences completes enrollment of Phase 2b trial of BPL-003March 6, 2025 | markets.businessinsider.comatai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant DepressionMarch 6, 2025 | finance.yahoo.comatai Life Sciences-backed trial in treatment-resistant depression completes patient enrollmentMarch 5, 2025 | proactiveinvestors.comIs Atai Life Sciences N.V. (ATAI) Among Stocks With At Least $20 Million In Insider Spending Recently?March 4, 2025 | insidermonkey.comAtai: Following The Path That Spravato Laid And Moving Beyond ItFebruary 27, 2025 | seekingalpha.comatai Life Sciences to Participate in the TD Cowen 45th Annual Health Care ConferenceFebruary 24, 2025 | globenewswire.comBiotechs Highlight 6 Stocks Insiders Are Buying NowFebruary 23, 2025 | 247wallst.comatai Life Sciences Completes $63.25 Million Public Offering to Advance Mental Health Treatment InitiativesFebruary 22, 2025 | nasdaq.comAtai Life Sciences announces full exercise of option to purchase sharesFebruary 20, 2025 | markets.businessinsider.comPsilera Inc. & atai Life Sciences Announce Licensing Agreement for DMT Patent PortfolioFebruary 20, 2025 | finance.yahoo.comatai Life Sciences completes public offering, raising $63.25MFebruary 20, 2025 | proactiveinvestors.comatai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common SharesFebruary 20, 2025 | globenewswire.comatai Life Sciences announces pricing of $55M public offering of sharesFebruary 13, 2025 | proactiveinvestors.comAtai Life Sciences: Promising Pipeline and Upcoming Catalysts Drive Buy RatingFebruary 13, 2025 | tipranks.comAtai Life Sciences 26.2M share Spot Secondary priced at $2.10February 13, 2025 | markets.businessinsider.comatai Life Sciences Announces Pricing of Public Offering of Common SharesFebruary 12, 2025 | globenewswire.comAtai Life Sciences announces $55M common shares offeringFebruary 12, 2025 | markets.businessinsider.comatai Life Sciences unveils $55M public offering to advance mental health treatmentsFebruary 12, 2025 | proactiveinvestors.comatai Life Sciences Announces Proposed Public Offering of Common SharesFebruary 12, 2025 | globenewswire.comAtai CEO Rao optimistic about psychedelic therapies despite Lykos setbackFebruary 11, 2025 | msn.comatai Life Sciences CEO discusses success of BPL-003 alcohol use disorder trial - ICYMIFebruary 8, 2025 | proactiveinvestors.comatai Life Sciences-backed psychedelic drug could offer superior value, analysts believeFebruary 6, 2025 | proactiveinvestors.comH.C. Wainwright Keeps Their Buy Rating on ATAI Life Sciences (ATAI)February 5, 2025 | markets.businessinsider.comatai Life Sciences gains as new data derisks upcoming treatment-resistant depression trial readoutFebruary 3, 2025 | proactiveinvestors.comTD Cowen Reaffirms Their Buy Rating on ATAI Life Sciences (ATAI)January 31, 2025 | markets.businessinsider.comAtai Life Sciences And 2 Other Promising Penny Stocks On US ExchangesJanuary 31, 2025 | finance.yahoo.comPsychedelic: atai Life Sciences reports BPL-003 study resultsJanuary 30, 2025 | markets.businessinsider.comAtai Life Sciences: Positive BPL-003 Data In AUD Leads To Another CatalystJanuary 29, 2025 | seekingalpha.comBPL-003 shows promise in alcohol use disorder studyJanuary 28, 2025 | msn.comAtai reports positive data for psychedelic drug BPL-003January 28, 2025 | msn.comAtai Life Sciences announces results from BPL-003 Phase 2a open-label studyJanuary 28, 2025 | markets.businessinsider.comATAI Life Sciences Rated Buy by Patrick Trucchio: Promising Phase 2a Trial Results and Favorable Valuation AnalysisJanuary 28, 2025 | markets.businessinsider.comatai Life Sciences poised for near-term value creation with release of psychedelics trial data: analystsJanuary 28, 2025 | proactiveinvestors.comatai Life Sciences unveils positive results from Beckley Psytech's alcohol use disorder trialJanuary 28, 2025 | proactiveinvestors.com Remove Ads Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address ATAI Media Mentions By Week ATAI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATAI News Sentiment▼-0.020.81▲Average Medical News Sentiment ATAI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATAI Articles This Week▼52▲ATAI Articles Average Week Remove Ads Get Atai Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CALT News Today GPCR News Today IOVA News Today SNDX News Today AUPH News Today SYRE News Today ELVN News Today MLYS News Today NRIX News Today VIR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATAI) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredMan Who Predicted 2008 Crash: “Move your money out of stocks TODAY”Could the recent tech sell-off indicate a looming market crash? Nvidia dropped 30% from its high... Pala...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atai Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Atai Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.